Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis
MSH6 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)
Amylase, Serum
LiquidHALLMARK Multi Cancer Panel
Tumor Suppressor Gene P53 (TP53) Gene Mutation Analysis
Cancer Antigen (CA) 19-9, Serum
Methylation Cancer Marker Detection in Cell-free Circulating Tumor DNA (Northstar Select and Response™)
Solid Tumor Gene Mutation Panel, NGS (Oncotype MAP™, Guardant360® CDx, Guardant Reveal™, PGDx elio™, Northstar Select®, oncoReveal™, LiquidHALLMARK®, PredicineATLAS™, PGDx elio™ Assay)
Gamma Glutamyl Transferase (GGT)
LDS
Sign up
Log in
LDS
/
Medical Tests
/
MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
Medical Test
Clinical Utility
Access to
MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
is restricted.
Sign up now
Loading...